BPG is committed to discovery and dissemination of knowledge
Featured Articles
11/15/2022 12:16:45 PM | Browse: 200 | Download: 636
 |
Received |
|
2022-08-04 03:24 |
 |
Peer-Review Started |
|
2022-08-04 03:26 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2022-09-30 17:56 |
 |
Revised |
|
2022-10-01 09:14 |
 |
Second Decision |
|
2022-10-31 03:34 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2022-10-31 18:19 |
 |
Articles in Press |
|
2022-10-31 18:19 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2022-11-01 08:28 |
 |
Publish the Manuscript Online |
|
2022-11-15 10:19 |
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Surgery |
Manuscript Type |
Minireviews |
Article Title |
Portal vein embolization failure: Current strategies and future perspectives to improve liver hypertrophy before major oncological liver resection
|
Manuscript Source |
Invited Manuscript |
All Author List |
Gianluca Cassese, Ho-Seong Han, Boram Lee, Jai Young Cho, Hae Won Lee, Boris Guiu, Fabrizio Panaro and Roberto Ivan Troisi |
Funding Agency and Grant Number |
|
Corresponding Author |
Ho-Seong Han, MD, PhD, Professor, Department of Surgery, Seoul National University College of Medicine, 166 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Seongnam 13620, South Korea. hanhs@snubh.org |
Key Words |
Portal vein embolization; Portal vein embolization failure; Rescue associating liver partition and portal vein ligation; Hepatic vein embolization; Liver venous deprivation; Segment 4 portal vein embolization |
Core Tip |
Portal vein embolization (PVE) is actually considered the standard of care for inducing volume augmentation of the future remnant liver. However, 20% of patients who have undergone PVE, reportedly never undergo curative resection, due to either insufficient FRL growth with an unacceptable risk of post-hepatectomy liver failure, or oncologic progression after PVE, while waiting for the adequate FRL hypertrophy (6-8 wk or more). The management of PVE failure is still highly debated, with different additional techniques that have been proposed, such as sequential transarterial chemoembolization followed by PVE, segment 4 PVE, intra-portal administration of stem cells, dietary supplementation, and hepatic vein embolization. |
Publish Date |
2022-11-15 10:19 |
Citation |
Cassese G, Han HS, Lee B, Cho JY, Lee HW, Guiu B, Panaro F, Troisi RI. Portal vein embolization failure: Current strategies and future perspectives to improve liver hypertrophy before major oncological liver resection. World J Gastrointest Oncol 2022; 14(11): 2088-2096 |
URL |
https://www.wjgnet.com/1948-5204/full/v14/i11/2088.htm |
DOI |
https://dx.doi.org/10.4251/wjgo.v14.i11.2088 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345